Dermatology Times Newsletter

To view this email as a web page, click here.

You’re reading Legal Eagle, a column where David J. Goldberg, M.D., J.D., answers your legal questions. This week Dr. Goldberg covers off-label drug promotion, medspa liability risks and needlestick injuries.

Off-label drug promotion or education?

A dermatologist attends a local dermatologic society meeting to obtain CME credits. The meeting is sponsored by a drug company that provides journal articles discussing off-label use of one of their newer biologic agents. Are they in violation of FDA rulings against promoting off-label use?

Medspa liability risks

This physician opens a medspa a few blocks away from his current office, and hires staff to perform a variety of energy-based procedures and injectables. Within a year, he is overwhelmed by over five medical malpractice lawsuits and three complaints to his local state Board of Medical Examiners. What are his legal issues?

Needlestick injuries

An employee was performing an excision on a patient who was on blood thinners. The patient requested that his blood thinners not be stopped for the procedure. During the surgery the physician was stuck with an 18-gauge needle. Now what?

From our Latest Issue

The case for hackathons in dermatology

Study examines port-wine stain treatment in infants

Brodalumab effective for psoriasis patients with skin of color

JOB OPPORTUNITIES

CA - Integrated Dermatology

CO-Integrated Dermatology

CT - Integrated Dermatology

District of Columbia-Integrated Dermatology

MA - Integrated Dermatology

MD - Integrated Dermatology

MS - Integrated Dermatology

National - Integrated Dermatology

NJ - Integrated Dermatology

NJ - Practice for Sale

NV - Integrated Dermatology

VA - Integrated Dermatology

VT - Integrated Dermatology

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.